Giovanni Di Perri

InstitutionUniversity of Turin
AddressTurin
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 26 Covid-19 publications, with a maximum of 4 publications in February 2021
    All Publications
    Bar chart showing 318 publications over 21 distinct years, with a maximum of 37 publications in 2014
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Airoldi C, Calcagno A, Di Perri G, Valinotto R, Gallo L, Locana E, Trunfio M, Patrucco F, Vineis P, Faggiano F. Seroprevalence of SARS-CoV-2 Among Workers in Northern Italy. Ann Work Expo Health. 2022 02 18; 66(2):224-232. PMID: 34365502.
      Citations:    Fields:    
    2. Robotto A, Lembo D, Quaglino P, Brizio E, Polato D, Civra A, Cusato J, Di Perri G. Wastewater-based SARS-CoV-2 environmental monitoring for Piedmont, Italy. Environ Res. 2022 Jan; 203:111901. PMID: 34419466.
      Citations:    Fields:    Translation:HumansPHPublic Health
    3. Cosma S, Carosso AR, Cusato J, Borella F, Carosso M, Gervasoni F, Stura I, Preti M, Ghisetti V, Di Perri G, Benedetto C. Preterm birth is not associated with asymptomatic/mild SARS-CoV-2 infection per se: Pre-pregnancy state is what matters. PLoS One. 2021; 16(8):e0254875. PMID: 34351922.
      Citations:    Fields:    Translation:Humans
    4. Corcione S, De Nicolò A, Montrucchio G, Scabini S, Avataneo V, Bonetto C, Mornese Pinna S, Cusato J, Canta F, Urbino R, Di Perri G, Brazzi L, De Rosa FG, D'Avolio A. Real-life study on the pharmacokinetic of remdesivir in ICU patients admitted for severe COVID-19 pneumonia. Br J Clin Pharmacol. 2021 12; 87(12):4861-4867. PMID: 33990984.
      Citations:    Fields:    Translation:Humans
    5. De Nicolò A, Avataneo V, Cusato J, Palermiti A, Mula J, De Vivo E, Antonucci M, Bonora S, Calcagno A, Di Perri G, De Rosa FG, D'Avolio A. Analytical Validation and Clinical Application of Rapid Serological Tests for SARS-CoV-2 Suitable for Large-Scale Screening. Diagnostics (Basel). 2021 May 12; 11(5). PMID: 34065954.
      Citations:    
    6. De Rosa FG, Palazzo A, Rosso T, Shbaklo N, Mussa M, Boglione L, Borgogno E, Rossati A, Mornese Pinna S, Scabini S, Chichino G, Borrè S, Del Bono V, Garavelli PL, Barillà D, Cattel F, Di Perri G, Ciccone G, Lupia T, Corcione S. Risk Factors for Mortality in COVID-19 Hospitalized Patients in Piedmont, Italy: Results from the Multicenter, Regional, CORACLE Registry. J Clin Med. 2021 May 01; 10(9). PMID: 34062864.
      Citations: 1     
    7. Trunfio M, Calcagno A, Bonora S, Di Perri G. Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases. Lancet Infect Dis. 2021 07; 21(7):914-915. PMID: 33864803.
      Citations: 2     Fields:    Translation:Humans
    8. Trunfio M, Longo BM, Alladio F, Venuti F, Cerutti F, Ghisetti V, Bonora S, Di Perri G, Calcagno A. On the SARS-CoV-2 "Variolation Hypothesis": No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases. Front Microbiol. 2021; 12:646679. PMID: 33815334.
      Citations: 4     
    9. Andreoni M, Di Perri G, Persico M, Marcellusi A, Ethgen O, Sanchez Gonzalez Y, Bondin M, Zhang Z, De Michina A, Merolla RCD, Craxì A. Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks' Glecaprevir/Pibrentasvir Therapy. Infect Dis Ther. 2021 Jun; 10(2):763-774. PMID: 33655410.
      Citations:    
    10. Baratta F, Visentin GM, Ravetto Enri L, Parente M, Pignata I, Venuti F, Di Perri G, Brusa P. Community Pharmacy Practice in Italy during the COVID-19 (SARS-CoV-2) Pandemic: Regulatory Changes and a Cross-Sectional Analysis of Seroprevalence. Int J Environ Res Public Health. 2021 02 26; 18(5). PMID: 33652711.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    11. Cosma S, Carosso AR, Borella F, Cusato J, Bovetti M, Bevilacqua F, Carosso M, Gervasoni F, Sciarrone A, Marozio L, Revelli A, Rolfo A, Filippini C, Ghisetti V, Di Perri G, Benedetto C. Prenatal Biochemical and Ultrasound Markers in COVID-19 Pregnant Patients: A Prospective Case-Control Study. Diagnostics (Basel). 2021 Feb 26; 11(3). PMID: 33652805.
      Citations: 2     
    12. Trunfio M, Venuti F, Alladio F, Longo BM, Burdino E, Cerutti F, Ghisetti V, Bertucci R, Picco C, Bonora S, Di Perri G, Calcagno A. Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients. Viruses. 2021 02 11; 13(2). PMID: 33670360.
      Citations: 12     Fields:    Translation:Humans
    13. Cosma S, Carosso AR, Corcione S, Cusato J, Borella F, Antonucci M, Marozio L, Revelli A, Preti M, Ghisetti V, Di Perri G, Benedetto C. Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery. J Reprod Immunol. 2021 04; 144:103285. PMID: 33582489.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    14. Mussini C, Falcone M, Nozza S, Sagnelli C, Parrella R, Meschiari M, Petrosillo N, Mastroianni C, Cascio A, Iaria C, Galli M, Chirianni A, Sagnelli E, Iacobello C, Di Perri G, Mazzotta F, Carosi G, Tinelli M, Grossi P, Armignacco O, Portelli V, Andreoni M, Tavio M. Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT). Clin Microbiol Infect. 2021 Mar; 27(3):389-395. PMID: 33359375.
      Citations: 9     Fields:    Translation:Humans
    15. Grosso A, Rigoli R, Formentini S, Di Perri G, Scotton P, Dapavo G, Fioretto M, Scarpa G. Suppression of Covid-19 outbreak among healthcare workers at the Treviso Regional Hospital, Italy and lessons for ophthalmologists. Eur J Ophthalmol. 2021 Nov; 31(6):2901-2909. PMID: 33319590.
      Citations:    Fields:    Translation:HumansPHPublic Health
    16. Cosma S, Carosso AR, Cusato J, Borella F, Carosso M, Bovetti M, Filippini C, D'Avolio A, Ghisetti V, Di Perri G, Benedetto C. Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients. Am J Obstet Gynecol. 2021 04; 224(4):391.e1-391.e7. PMID: 33039396.
      Citations: 30     Fields:    Translation:Humans
    17. Trunfio M, Salvador E, Cabodi D, Marinaro L, Alcantarini C, Gaviraghi A, Trentalange A, Lipani F, Sciascia S, Roccatello D, Bonora S, Di Perri G, Calcagno A. Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection. Thromb Res. 2020 12; 196:432-434. PMID: 33049598.
      Citations: 2     Fields:    Translation:Humans
    18. Calcagno A, Ghisetti V, Emanuele T, Trunfio M, Faraoni S, Boglione L, Burdino E, Audagnotto S, Lipani F, Nigra M, D'Avolio A, Bonora S, Di Perri G. Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy. Emerg Infect Dis. 2021 Jan; 27(1). PMID: 33021927.
      Citations: 14     Fields:    Translation:Humans
    19. Siccardi M, Schapiro J, Di Perri G, Back DJ. The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeutics. J Antimicrob Chemother. 2020 09 01; 75(9):2381-2383. PMID: 32591771.
      Citations:    Fields:    Translation:HumansAnimalsCellsPHPublic Health
    20. Calcagno A, Ghisetti V, Burdino E, Trunfio M, Allice T, Boglione L, Bonora S, Di Perri G. Co-infection with other respiratory pathogens in COVID-19 patients. Clin Microbiol Infect. 2021 Feb; 27(2):297-298. PMID: 32822882.
      Citations: 15     Fields:    Translation:HumansCells
    21. Cosma S, Borella F, Carosso A, Sciarrone A, Cusato J, Corcione S, Mengozzi G, Preti M, Katsaros D, Di Perri G, Benedetto C. The "scar" of a pandemic: Cumulative incidence of COVID-19 during the first trimester of pregnancy. J Med Virol. 2021 01; 93(1):537-540. PMID: 32633869.
      Citations: 19     Fields:    Translation:Humans
    22. Avataneo V, de Nicolò A, Cusato J, Antonucci M, Manca A, Palermiti A, Waitt C, Walimbwa S, Lamorde M, di Perri G, D'Avolio A. Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease. J Antimicrob Chemother. 2020 07 01; 75(7):1772-1777. PMID: 32361744.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    23. Di Perri G. The rationale for Low-Molecular Weight Heparin (LMWH) use in SARS-CoV-2 infection Infez Med. 2020 06 01; 28(suppl 1):52-56. PMID: 32532939.
      Citations:    Fields:    Translation:HumansPHPublic Health
    24. Sciascia S, Aprà F, Baffa A, Baldovino S, Boaro D, Boero R, Bonora S, Calcagno A, Cecchi I, Cinnirella G, Converso M, Cozzi M, Crosasso P, De Iaco F, Di Perri G, Eandi M, Fenoglio R, Giusti M, Imperiale D, Imperiale G, Livigni S, Manno E, Massara C, Milone V, Natale G, Navarra M, Oddone V, Osella S, Piccioni P, Radin M, Roccatello D, Rossi D. Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. Clin Exp Rheumatol. 2020 May-Jun; 38(3):529-532. PMID: 32359035.
      Citations: 135     Fields:    Translation:HumansCellsPHPublic Health
    25. Carosso A, Cosma S, Borella F, Marozio L, Coscia A, Ghisetti V, Di Perri G, Benedetto C. Pre-labor anorectal swab for SARS-CoV-2 in COVID-19 pregnant patients: is it time to think about it? Eur J Obstet Gynecol Reprod Biol. 2020 Jun; 249:98-99. PMID: 32327266.
      Citations: 29     Fields:    Translation:HumansCellsPHPublic Health
    26. Lupia T, Scabini S, Mornese Pinna S, Di Perri G, De Rosa FG, Corcione S. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist. 2020 06; 21:22-27. PMID: 32156648.
      Citations: 92     Fields:    Translation:HumansCellsPHPublic Health
    27. Trunfio M, Salvador E, Gaviraghi A, Audagnotto S, Marinaro L, Motta I, Casciaro R, Ghisetti V, Fava C, Bonora S, Di Perri G, Calcagno A. Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativity. Antivir Ther. 2020; 25(6):327-333. PMID: 33506810.
      Citations: 1     Fields:    Translation:Humans
    Di Perri's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (357)
    Explore
    _
    Co-Authors (197)
    Explore
    _
    Similar People (60)
    Explore
    _